Drug Delivery Systems : Market Research Report

Drug Delivery Systems

Published: Mar. 1, 2008 - 338 Pages

INTRODUCTION
I. EXECUTIVE SUMMARY
II. MARKET ENVIRONMENT
General
Macroeconomic Trends
Demographic Patterns
Health Care Trends: Health Insurance; Medical Conditions; National Health Expenditures; Medical Providers; Patient Activity
Pharmaceutical Market Overview: Regulation; Research & Development; Demand Patterns & Forecasts
III. DRUG DELIVERY MATERIALS
General
Sterile & Purified Water
Synthetic Polymers: Polyethylene Glycol (PEG); Acrylic Polymers; Polyethylene Oxide; Polyvinyl Alcohol; Other Synthetic Polymers
Cellulose Derivatives: Ethyl Cellulose; Hydroxypropyl Methylcellulose (HPMC); Other Cellulose Derivatives
Minerals: Mineral Hydrocarbons; Other Minerals
Other Drug Delivery Materials: Starch Compounds; Sugars & Polyols; Natural Gums; All Other Drug Delivery Materials
IV. DRUG DELIVERY SYSTEMS OVERVIEW
General
Types of Drug Delivery Systems
Historical Demand Patterns
Regulation
Research & Development
US Trade
International Markets
V. ORAL DRUG DELIVERY SYSTEMS
General
Controlled-Release Formulations: Technologies; Coated Systems; Diffusion Systems; Reservoir Systems
Chewable Tablets
Orally Disintegrating Tablets
Nanoparticulate Formulations: Ethical Pharmaceuticals; Over-the-Counter Drugs
Transmucosal Formulations
VI. PARENTERAL DRUG DELIVERY SYSTEMS
General
Therapeutic Monoclonal Antibodies: Technology; Anti-Cancer Agents; Other Therapeutic Monoclonal Antibodies; Products in Development
Prefilled Syringes: Applications; Injectors; Cartridges & Insulin Pens
Encapsulated Systems: Polymer-Protected Systems; Liposomes; Developmental Activities
Premixed IV Solutions: Mini-Bags; Bag/Vial Infusion Systems; Applications
VII. INHALATION, TRANSDERMAL & IMPLANTABLE DRUG DELIVERY SYSTEMS
General
Inhalation Drug Delivery Systems: Dry Powder Formulations; Metered Dose Formulations
Transdermal Drug Delivery Systems: Products & Technologies; Developers & Suppliers; Applications
Implantable Drug Delivery Systems: Drug-Eluting Stents; Drug Inserts; Brachytherapy
VIII. APPLICATIONS
General
Central Nervous System Agents
Respiratory Agents
Hormones & Related Agents
Gastrointestinal Agents
Cardiovascular Agents
Anti-Infective Agents
Nutritional Agents
Biologicals
Genito-Urinary Agents
Other Therapies
IX. INDUSTRY STRUCTURE
General
Developmental Revenues
Market Share
Competitive Strategies
Mergers & Acquisitions
Licensing & Related Agreements
Marketing & Distribution
Manufacturing
Company Profiles: Alkermes Incorporated; AptarGroup Incorporated; Aradigm Corporation; Associated British Foods plc; Aveva Drug Delivery Systems, see Nitto Denko; Baxter International Incorporated; Becton, Dickinson and Company; Bespak, see Consort Medical; Cardinal Health Pharmaceutical Technologies and Services, see Catalent Pharma Solutions; Catalent Pharma Solutions Incorporated; Cephalon Incorporated; CIMA LABS, see Cephalon; Consort Medical plc; Corium International Incorporated; CyDex Pharmaceuticals Incorporated; Depomed Incorporated; Dow Corning Corporation; DURECT Corporation; Elan Corporation plc; Emisphere Technologies Incorporated; Encore Medical, see ReAble Therapeutics; Eurand NV; Flamel Technologies SA; Genzyme Corporation; Hospira Incorporated; IOMED, see ReAble Therapeutics; Johnson & Johnson; Nastech Pharmaceutical Company Incorporated; Nektar Therapeutics; Nitto Denko Corporation; NOF Corporation; Penwest Pharmaceuticals Company; ReAble Therapeutics Incorporated; Safety Syringes Incorporated; SPI Pharma, see Associated British Foods; StrataGent Life Sciences, see Corium International; 3M Company; Valeritas LLC; Valois SAS, see AptarGroup; Other Companies Mentioned in Study
LIST OF TABLES
SECTION I -- EXECUTIVE SUMMARY: Summary Table
SECTION II -- MARKET ENVIRONMENT: 1 Macroeconomic Indicators; 2 Population by Age Group; 3 Acute Conditions by Type; 4 Chronic Conditions by Type; 5 National Health Expenditures by Type; 6 Medical Providers by Type; 7 Patient Activity by Type; 8 Pharmaceutical Demand by Therapeutic Class; 9 Pharmaceutical Demand by Commercial Status; 10 Pharmaceutical Demand by Dosage Formulation; 11 Pharmaceutical Demand by Regulatory Classification
SECTION III -- DRUG DELIVERY MATERIALS: 1 Drug Delivery Material Demand by Type; 2 Sterile & Purified Water Demand in Drug Delivery; 3 Synthetic Polymer Demand in Drug Delivery; 4 Cellulose Derivative Demand in Drug Delivery; 5 Mineral Demand in Drug Delivery; 6 Other Material Demand in Drug Delivery
SECTION IV -- DRUG DELIVERY SYSTEMS OVERVIEW: 1 Drug Delivery System Demand by Dosage Formulation; 2 Drug Delivery System Demand, 1997-2007; 3 US Trade in Drug Delivery Systems; 4 World Drug Delivery System Demand by Region
SECTION V -- ORAL DRUG DELIVERY SYSTEMS: 1 Oral Drug Delivery System Demand by Type; 2 Oral Controlled-Release Drug Delivery System Demand; 3 Coated Controlled-Release Drug Delivery System Demand; 4 Diffusion Controlled-Release Drug Delivery System Demand; 5 Reservoir Controlled-Release Drug Delivery System Demand; 6 Chewable Tablet Demand by Therapeutic Class; 7 Orally Disintegrating Tablet Demand by Therapeutic Class; 8 Nanoparticulate Oral Drug Delivery System Demand by Therapeutic Class; 9 Oral Transmucosal Drug Delivery System Demand by Therapeutic Class
SECTION VI -- PARENTERAL DRUG DELIVERY SYSTEMS: 1 Parenteral Drug Delivery System Demand by Type; 2 Therapeutic Monoclonal Antibody Demand by Therapeutic Class; 3 Therapeutic Monoclonal Antibodies Approved for US Sale; 4 Prefilled Syringe Demand by Therapeutic Class; 5 Encapsulated Parenteral Drug Delivery System Demand by Type & Therapeutic Class; 6 Premixed IV Solution Demand by Therapeutic Class
SECTION VII -- INHALATION, TRANSDERMAL & IMPLANTABLE DRUG DELIVERY SYSTEMS: 1 Other Drug Delivery System Demand by Type; 2 Inhalation Drug Delivery System Demand by Type & Therapeutic Class; 3 Transdermal Drug Delivery System Demand by Therapeutic Class; 4 Implantable Drug Delivery System Demand by Type & Therapeutic Class
SECTION VIII -- APPLICATIONS: 1 Drug Delivery System Demand by Therapeutic Class; 2 Central Nervous System Drug Delivery Demand by Type; 3 Respiratory Drug Delivery Demand by Type; 4 Hormone & Related Drug Delivery Demand by Type; 5 Gastrointestinal Drug Delivery System Demand by Type; 6 Cardiovascular Drug Delivery System Demand by Type; 7 Anti-Infective Drug Delivery System Demand by Type; 8 Nutritional Delivery System Demand by Type; 9 Biological Delivery System Demand by Type; 10 Genito-Urinary Drug Delivery System Demand; 11 Drug Delivery System Demand in Other Therapies
SECTION IX -- INDUSTRY STRUCTURE: 1 Drug Delivery Revenues by Company, 2007; 2 Selected Acquisitions & Divestitures; 3 Selected Cooperative Agreements
LIST OF CHARTS
SECTION III -- DRUG DELIVERY MATERIALS: 1 Drug Delivery Material Demand by Type, 2007
SECTION IV -- DRUG DELIVERY SYSTEMS OVERVIEW: 1 Drug Delivery System Demand by Dosage Formulation, 2007
SECTION V -- ORAL DRUG DELIVERY SYSTEMS: 1 Oral Drug Delivery System Demand by Type, 2007
SECTION VI -- PARENTERAL DRUG DELIVERY SYSTEMS: 1 Parenteral Drug Delivery System Demand by Type, 2007
SECTION VII -- INHALATION, TRANSDERMAL & IMPLANTABLE DRUG DELIVERY SYSTEMS: 1 Inhalation, Transdermal & Implantable Drug Delivery; System Demand by Type, 2007
SECTION VIII -- APPLICATIONS: 1 Drug Delivery System Demand by Therapeutic Class, 2007
SECTION IX -- INDUSTRY STRUCTURE: 1 US Drug Delivery Product Sales by Company, 2007

Abstract

Demand to grow more than 10% annually through 2012
US demand for drug delivery systems is projected to expand more than ten percent annually to $132 billion in 2012. Growth opportunities for drug delivery systems extend into all therapeutic classes of pharmaceuticals and encompass a wide range of compounds and formulations. Central nervous system, respiratory and hormone and related agents will remain the top three applications based on the special formulating needs of medicines for conditions such as arthritis, multiple sclerosis, asthma, allergies and cancer. However, favorable growth opportunities will emerge for drug delivery systems in most other therapeutic classes due to safety and efficacy shortcomings in many conventional medicines.

Please Note: Freedonia requires that, for PDF orders, clients sign a confidentiality agreement prior to fulfillment of PDF email delivery.

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

Drug Delivery Systems

Table of Contents

Abstract